Join
Live feed
·
PRReleasevia Quantisnow
Ikena Oncology Inc. logo
Poseida Therapeutics Inc. logo

Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company

ByQuantisnow·Wall Street's wire, on your screen.
IKNA· Ikena Oncology Inc.PSTX· Poseida Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IKNA (Ikena Oncology Inc.), PSTX (Poseida Therapeutics Inc.) and more on Quantisnow.